Johnson & Johnson expects to report trial data next week for one dose vaccine

Johnson & Johnson expects to report trial data next week for one dose vaccine
Johnson & Johnson expects to report trial data next week for one dose vaccine

Yahoo Finance’s Anjalee Khemlani breaks down the latest news on the Johnson & Johnson COVID-19 vaccine. Also, Pfizer reports completing the enrollment for 12-15 year old vaccine group, Regeneron releases press release on positive results on cocktail antibody therapy, and new Brazil based variant is found in Minnesota.